Man Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Sell |
94,618
-43,984
| -32% | -$512K | ﹤0.01% | 1395 |
|
|
2025
Q1 | $1.03M | Sell |
138,602
-150,087
| -52% | -$1.12M | ﹤0.01% | 1368 |
|
|
2024
Q4 | $1.73M | Buy |
288,689
+128,317
| +80% | +$769K | ﹤0.01% | 1219 |
|
|
2024
Q3 | $821K | Sell |
160,372
-24,079
| -13% | -$123K | ﹤0.01% | 1410 |
|
|
2024
Q2 | $668K | Buy |
184,451
+6,444
| +4% | +$23.3K | ﹤0.01% | 1468 |
|
|
2024
Q1 | $571K | Buy |
178,007
+6,938
| +4% | +$22.3K | ﹤0.01% | 1619 |
|
|
2023
Q4 | $838K | Buy |
+171,069
| New | +$838K | ﹤0.01% | 1401 |
|
|
2023
Q3 | – | Sell |
-122,508
| Closed | -$822K | – | 1420 |
|
|
2023
Q2 | $822K | Buy |
+122,508
| New | +$822K | ﹤0.01% | 1421 |
|
|
2023
Q1 | – | Sell |
-93,764
| Closed | -$716K | – | 1343 |
|
|
2022
Q4 | $716K | Sell |
93,764
-59,287
| -39% | -$453K | ﹤0.01% | 1414 |
|
|
2022
Q3 | $1.09M | Buy |
+153,051
| New | +$1.09M | 0.01% | 1235 |
|
|
2022
Q2 | – | Sell |
-89,698
| Closed | -$1.25M | – | 1228 |
|
|
2022
Q1 | $1.25M | Buy |
89,698
+8,102
| +10% | +$112K | ﹤0.01% | 1310 |
|
|
2021
Q4 | $2.29M | Sell |
81,596
-26,981
| -25% | -$757K | 0.01% | 1140 |
|
|
2021
Q3 | $3.69M | Sell |
108,577
-364
| -0.3% | -$12.4K | 0.01% | 962 |
|
|
2021
Q2 | $4.45M | Sell |
108,941
-35,794
| -25% | -$1.46M | 0.02% | 933 |
|
|
2021
Q1 | $5.83M | Buy |
144,735
+3,029
| +2% | +$122K | 0.03% | 618 |
|
|
2020
Q4 | $8.38M | Sell |
141,706
-3,398
| -2% | -$201K | 0.04% | 512 |
|
|
2020
Q3 | $7.06M | Sell |
145,104
-11,527
| -7% | -$561K | 0.03% | 632 |
|
|
2020
Q2 | $7.58M | Buy |
156,631
+134,288
| +601% | +$6.5M | 0.04% | 473 |
|
|
2020
Q1 | $621K | Sell |
22,343
-408,466
| -95% | -$11.4M | ﹤0.01% | 1223 |
|
|
2019
Q4 | $12.9M | Buy |
430,809
+369,397
| +602% | +$11.1M | 0.04% | 553 |
|
|
2019
Q3 | $1.9M | Buy |
+61,412
| New | +$1.9M | 0.01% | 1255 |
|